CEREVEL THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Accrued Liabilities
CEREVEL THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Accrued Liabilities of -$7.25 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2024-05-08
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-03-31 was -$7.25M.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2023-12-31 was $13.32M, a 23.89% decline year-over-year.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2023-09-30 was $10.57M.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2023-06-30 was $779.00K, a 95.85% decline year-over-year.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $17.41M, a 43.48% decline from fiscal 2022.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $30.81M, a 255.25% increase from fiscal 2021.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2021 was $8.67M, a 18.88% decline from fiscal 2020.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2020 was $10.69M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 4 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 7 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2024-03-31 | -$7.25M 10-Q · filed 2024-05-08 | $6.08M derived: sum of 2 quarters · filed 2024-05-08 | $16.65M derived: sum of 3 quarters · filed 2024-05-08 | $17.43M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2023-12-31 | $13.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $23.89M derived: sum of 2 quarters · filed 2024-02-27 | $24.67M derived: sum of 3 quarters · filed 2024-02-27 | $17.41M 10-K · filed 2024-02-27 | ||
| 2023-09-30 | $10.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $11.35M derived: sum of 2 quarters · filed 2023-11-01 | $4.09M 10-Q · filed 2023-11-01 | $21.59M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2023-06-30 | $779.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$6.48M 10-Q · filed 2023-08-02 | $11.02M derived: sum of 3 quarters · filed 2024-05-08 | $10.18M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2023-03-31 | -$7.26M 10-Q · filed 2024-05-08 | $10.24M derived: sum of 2 quarters · filed 2024-05-08 | $9.40M derived: sum of 3 quarters · filed 2024-05-08 | $28.16M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | $17.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $16.66M derived: sum of 2 quarters · filed 2024-02-27 | $35.42M derived: sum of 3 quarters · filed 2024-02-27 | $30.81M 10-K · filed 2024-02-27 | ||
| 2022-09-30 | -$838.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $17.92M derived: sum of 2 quarters · filed 2023-11-01 | $13.30M 10-Q · filed 2023-11-01 | $19.17M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $18.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $14.14M 10-Q · filed 2023-08-02 | $20.01M derived: sum of 3 quarters · filed 2024-02-27 | $21.49M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | -$4.61M 10-Q · filed 2023-05-03 | $1.25M derived: sum of 2 quarters · filed 2024-02-27 | $2.73M derived: sum of 3 quarters · filed 2024-02-27 | $2.08M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $7.35M derived: sum of 2 quarters · filed 2024-02-27 | $6.70M derived: sum of 3 quarters · filed 2024-02-27 | $8.67M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $831.00K derived: sum of 2 quarters · filed 2022-11-08 | $2.81M 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | -$650.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $1.32M 10-Q · filed 2022-08-01 | ||||
| 2021-03-31 | $1.98M 10-Q · filed 2022-05-10 | |||||
| 2020-12-31 | $10.69M 10-K · filed 2023-02-22 | |||||
| 2020-09-30 | $2.55M 10-Q · filed 2020-11-16 | |||||
| 2020-06-30 | $139.84K 10-Q · filed 2020-08-14 |